Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Seufferlein

Showing results (211-220 of 367) with videos related to

Pageof 37
Sort By:
Gut|August 25, 2010
Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumoursNinel Azoitei, Ganesh Varma Pusapati, Alexander Kleger, et al.
BMC Surgery|January 10, 2009
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancerAndre Mihaljevic, Peter Büchler, Jan Harder, et al.
Theranostics|April 17, 2023
Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoidsSarah Merz, Markus Breunig, Michael Karl Melzer, et al.
JHEP Reports : Innovation in Hepatology|August 4, 2020
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related diseaseLucas A Schulte, Frank Arnold, Florian Siegel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2020
Smartphone Application to Reinforce Education Increases High-Quality Preparation for Colorectal Cancer Screening Colonoscopies in a Randomized TrialBenjamin Walter, Rena Frank, Leopold Ludwig, et al.
Cancers|October 29, 2020
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa StudyBeate Schultheis, Dirk Strumberg, Jan Kuhlmann, et al.
Anti-Cancer Drugs|July 17, 2014
Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding studyMareile Joka, Stefan Boeck, Christoph J Zech, et al.
Cancer Treatment Reviews|June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidenceThomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.
Cellular Signalling|February 12, 2008
Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cellsGötz von Wichert, Teresa Edenfeld, Julia von Blume, et al.
Carcinogenesis|January 10, 2020
Sildenafil triggers tumor lethality through altered expression of HSP90 and degradation of PKD2Lu Chen, Yang Liu, Alexander Becher, et al.
Pageof 37

Showing results (211-220 of 367) with videos related to

Sort By:
Pageof 37
Gut|August 25, 2010
Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumoursNinel Azoitei, Ganesh Varma Pusapati, Alexander Kleger, et al.
BMC Surgery|January 10, 2009
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancerAndre Mihaljevic, Peter Büchler, Jan Harder, et al.
Theranostics|April 17, 2023
Single-cell profiling of GP2-enriched pancreatic progenitors to simultaneously create acinar, ductal, and endocrine organoidsSarah Merz, Markus Breunig, Michael Karl Melzer, et al.
JHEP Reports : Innovation in Hepatology|August 4, 2020
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related diseaseLucas A Schulte, Frank Arnold, Florian Siegel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2020
Smartphone Application to Reinforce Education Increases High-Quality Preparation for Colorectal Cancer Screening Colonoscopies in a Randomized TrialBenjamin Walter, Rena Frank, Leopold Ludwig, et al.
Cancers|October 29, 2020
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa StudyBeate Schultheis, Dirk Strumberg, Jan Kuhlmann, et al.
Anti-Cancer Drugs|July 17, 2014
Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding studyMareile Joka, Stefan Boeck, Christoph J Zech, et al.
Cancer Treatment Reviews|June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidenceThomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.
Cellular Signalling|February 12, 2008
Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cellsGötz von Wichert, Teresa Edenfeld, Julia von Blume, et al.
Carcinogenesis|January 10, 2020
Sildenafil triggers tumor lethality through altered expression of HSP90 and degradation of PKD2Lu Chen, Yang Liu, Alexander Becher, et al.
Pageof 37